Bridgewater, NJ, United States of America

Brent L Podlogar

This inventor holds 1 USPTO granted patent. Top assignee: Merrell Pharmaceuticals, Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brent L Podlogar. Retrieved from https://idiyas.com/inventor/brent-l-podlogar-iswnfdsi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brent L Podlogar: Innovator in Antiviral Agents

Introduction

Brent L Podlogar is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral agents. His work is characterized by a focus on innovative chemical compounds that can combat viral infections.

Latest Patents

Brent holds a patent for "Macrocyclic difluorostatone derivatives useful as antiviral agents." This patent highlights his expertise in creating novel compounds that have the potential to serve as effective treatments against various viral diseases. The patent showcases his innovative approach to drug development.

Career Highlights

Brent is currently employed at Merrell Pharmaceuticals, Inc., where he continues to advance his research in antiviral therapies. His role at the company allows him to collaborate with other experts in the field and contribute to the development of new pharmaceutical products.

Collaborations

One of Brent's notable collaborators is Robert A Farr. Together, they work on projects that aim to enhance the efficacy of antiviral treatments. Their partnership exemplifies the importance of teamwork in the field of pharmaceutical research.

Conclusion

Brent L Podlogar is a dedicated inventor whose work in antiviral agents has the potential to make a significant impact on public health. His innovative spirit and commitment to research continue to drive advancements in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…